Bimekizumab improves health status and work productivity, with reduced productivity costs, to 3 years in axial spondyloarthritis and psoriatic arthritis
Loading...
Contact
Check for full-text access
Issue Date
Type
Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
License
Journal
The Journal of Rheumatology